Related Articles
Associations of the BRAF (V600E) mutation and p53 protein expression with clinicopathological features of papillary thyroid carcinomas patients
Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma
pS2 expression as a possible diagnostic marker of colorectal carcinoma in ulcerative colitis.
Mutation in the K-ras gene at codon 12 does not correlate with disease progression in colorectal carcinoma patients treated with 5-FU/folinic acid biomodulated chemotherapy
Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of response to radiotherapy.